[HTML][HTML] A two-pill sublingual misoprostol outpatient regimen following mifepristone for medical abortion through 70 days' LMP: a prospective comparative open-label …
H Bracken, R Dabash, G Tsertsvadze, S Posohova… - Contraception, 2014 - Elsevier
Objective To test the effectiveness and acceptability of an outpatient medical abortion
protocol with 200 mg mifepristone and 400 mcg sublingual misoprostol at 64–70 days' last …
protocol with 200 mg mifepristone and 400 mcg sublingual misoprostol at 64–70 days' last …
A two-pill sublingual misoprostol outpatient regimen following mifepristone for medical abortion through 70 days' LMP: a prospective comparative open-label trial
H Bracken, R Dabash, G Tsertsvadze, S Posohova… - Contraception, 2014 - infona.pl
To test the effectiveness and acceptability of an outpatient medical abortion protocol with
200 mg mifepristone and 400 mcg sublingual misoprostol at 64–70 days' last menstrual …
200 mg mifepristone and 400 mcg sublingual misoprostol at 64–70 days' last menstrual …
[HTML][HTML] A two-pill sublingual misoprostol outpatient regimen following mifepristone for medical abortion through 70 days' LMP: a prospective comparative open-label …
H Bracken, R Dabash, G Tsertsvadze… - …, 2014 - contraceptionjournal.org
Objective To test the effectiveness and acceptability of an outpatient medical abortion
protocol with 200 mg mifepristone and 400 mcg sublingual misoprostol at 64–70 days' last …
protocol with 200 mg mifepristone and 400 mcg sublingual misoprostol at 64–70 days' last …
[PDF][PDF] A two-pill sublingual misoprostol outpatient regimen following mifepristone for medical abortion through 70 days' LMP: a prospective comparative open-label …
H Brackena, R Dabasha, G Tsertsvadzeb… - …, 2014 - academia.edu
Objective: To test the effectiveness and acceptability of an outpatient medical abortion
protocol with 200 mg mifepristone and 400 mcg sublingual misoprostol at 64–70 days' last …
protocol with 200 mg mifepristone and 400 mcg sublingual misoprostol at 64–70 days' last …
A two-pill sublingual misoprostol outpatient regimen following mifepristone for medical abortion through 70 days' LMP: a prospective comparative open-label trial
H Bracken, R Dabash, G Tsertsvadze… - …, 2014 - pubmed.ncbi.nlm.nih.gov
Objective To test the effectiveness and acceptability of an outpatient medical abortion
protocol with 200 mg mifepristone and 400 mcg sublingual misoprostol at 64-70 days' last …
protocol with 200 mg mifepristone and 400 mcg sublingual misoprostol at 64-70 days' last …
[引用][C] A two-pill sublingual misoprostol outpatient regimen following mifepristone for medical abortion through 70 days' LMP: a prospective comparative open-label …
H BRACKEN, R DABASH, I PLATAIS… - Contraception …, 2014 - pascal-francis.inist.fr
A two-pill sublingual misoprostol outpatient regimen following mifepristone for medical abortion
through 70 days' LMP: a prospective comparative open-label trial CNRS Inist Pascal-Francis …
through 70 days' LMP: a prospective comparative open-label trial CNRS Inist Pascal-Francis …
[PDF][PDF] A two-pill sublingual misoprostol outpatient regimen following mifepristone for medical abortion through 70 days' LMP: a prospective comparative open-label …
H Bracken, R Dabash, G Tsertsvadze, S Posohova… - …, 2014 - cyberleninka.org
Objective: To test the effectiveness and acceptability of an outpatient medical abortion
protocol with 200 mg mifepristone and 400 mcg sublingual misoprostol at 64–70 days' last …
protocol with 200 mg mifepristone and 400 mcg sublingual misoprostol at 64–70 days' last …
A two-pill sublingual misoprostol outpatient regimen following mifepristone for medical abortion through 70 days' LMP: a prospective comparative open-label trial.
H Bracken, R Dabash, G Tsertsvadze, S Posohova… - …, 2013 - europepmc.org
Objective To test the effectiveness and acceptability of an outpatient medical abortion
protocol with 200 mg mifepristone and 400 mcg sublingual misoprostol at 64-70 days' last …
protocol with 200 mg mifepristone and 400 mcg sublingual misoprostol at 64-70 days' last …
[引用][C] A two-pill sublingual misoprostol outpatient regimen following mifepristone for medical abortion through 70 days' LMP: A prospective comparative open-label …
H Bracken, R Dabash, I Platais, B Winikoff… - Contraception, 2014 - elibrary.ru
BRACKEN H.* 1, DABASH R. 1, PLATAIS I. 1, WINIKOFF B. 1, TSERTSVADZE G. 2,
POSOHOVA S. 3, SHAH M. 4, HAJRI S. 5, MUNDLE S. 6, CHELLI H. 7, ZERAMDINI D. 8 …
POSOHOVA S. 3, SHAH M. 4, HAJRI S. 5, MUNDLE S. 6, CHELLI H. 7, ZERAMDINI D. 8 …